Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Flash
20:17
Verastem Oncology announced that its oral inhibitor VS-7375, targeting Kras G12d-mutated metastatic pancreatic cancer, has completed dosing for the first patient in the Target-D 201 phase II registration-directed study.
This pivotal study aims to evaluate the efficacy and safety of the drug, marking a substantial step forward for this innovative therapy toward potential registration and market launch. VS-7375 is a novel Kras G12d (on/off) inhibitor, designed to precisely target this specific gene mutation commonly found in pancreatic cancer.
20:17
According to a filing submitted to the U.S. Securities and Exchange Commission, the merger plan between Webster Bank, a subsidiary of Webster Financial, and Santander Bank has received regulatory approval.
This transaction is expected to be officially completed on June 12, 2026. The approval of this merger marks a key milestone in the integration process of the two financial institutions and is expected to have an impact on the relevant market landscape.
20:17
According to documents submitted to the US Securities and Exchange Commission (SEC), American Airlines announced that its Vice Chairman and Chief Strategy Officer, Stephen L. Johnson, plans to retire by the end of this year.
The personnel change in this key position marks an important adjustment in the leadership of American Airlines. As a core figure in the company's strategic planning, Johnson's retirement will undoubtedly have an impact on the future business layout. Currently, the company has not yet announced specific arrangements for his successor. The market is closely watching how American Airlines will fill this high-level vacancy and whether the subsequent strategic direction will shift as a result.
Markets